Noncanonical Differentiation of Memory B Cells Drives Latent Tuberculosis Infection Reactivation Upon Tumor Necrosis Factor‐Alpha Inhibitor Therapy: An Integrative Transcriptomic Study
- 21 July 2025
- journal article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 28 (7) , e70311
Abstract
Aim: Tumor necrosis factor inhibitors (TNFi) are widely used for the treatment of autoimmune diseases, with latent tuberculosis infection (LTBI) reactivation being a significant unresolved issue. The pathogenic mechanisms are not fully understood. Integrated transcriptomic analysis could provide insights into monitoring tuberculosis progression after TNFi therapy and help reduce LTBI reactivation. Methods: We selected six transcriptomic datasets from studies related to TNFi treatment and tuberculosis. Pathway enrichment, pseudotime, and transcription factor analyses were performed to explore the underlying mechanisms. Results: Our analysis revealed distinct transcriptional changes in memory B cells during tuberculosis progression and TNFi therapy. In active tuberculosis (ATB), ROR1 + memory B cells were identified in a noncanonical differentiation trajectory, characterized by downregulation of B cell‐related genes (e.g., CD22, EBF1, MS4A1), reduced translational capacity, and suppression of immune response pathways, accompanied by upregulation of oxidative phosphorylation, which highlighted metabolic alterations during tuberculosis progression. A similar subtype also emerged in TNFi‐treated patients, suggesting that metabolic reprogramming of memory B cells may disrupt immune balance, thereby contributing to LTBI reactivation and ATB development following TNFi therapy. Conclusions: The study integrates bioinformatics and single‐cell RNA sequencing to reveal the role of memory B cells in ATB progression and TNFi treatment, offering insights into TNFi‐associated TB susceptibility and potential therapeutic targets.Keywords
Funding Information
- Guangdong Provincial Applied Science and Technology Research and Development Program
This publication has 40 references indexed in Scilit:
- Memory B cell fitness and anergy has significant links to cancer lethalityCell, 2024
- BCR signaling in germinal center B cell selectionTrends in Immunology, 2024
- Disseminated mycobacterial infections after tumor necrosis factor inhibitor use, revealing inborn errors of immunityInternational Journal of Infectious Diseases, 2023
- Risk of active tuberculosis in patients with inflammatory arthritis receiving TNF inhibitors: a look beyond the baseline tuberculosis screening protocolClinical Rheumatology, 2017
- IL-10–overexpressing B cells regulate innate and adaptive immune responsesJournal of Allergy and Clinical Immunology, 2015
- The extrapulmonary dissemination of tuberculosis: A meta-analysisInternational Journal of Mycobacteriology, 2014
- Comparison of tuberculosis incidence in ankylosing spondylitis and rheumatoid arthritis during tumor necrosis factor inhibitor treatment in an intermediate burden areaClinical Rheumatology, 2013
- FCRL3 promotes TLR9‐induced B‐cell activation and suppresses plasma cell differentiationEuropean Journal of Immunology, 2013
- Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque modelArthritis & Rheumatism, 2010
- The human mitochondrial proteome: oxidative stress, protein modifications and oxidative phosphorylationThe International Journal of Biochemistry & Cell Biology, 2005